Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Southern California
With
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
PRIMARY OBJECTIVE:
I. To develop a multi-level data-driven intervention to improve cancer patient engagement with cancer clinical trials.
OUTLINE: This is an observational study.
Patients review educational materials and complete surveys on study.
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Eligible patient participants will be:
* Black/African American, Asian/Asian American, White or Hispanic adults of any gender 21 years of age or older. Race/ethnicity will be self-reported
* Have been diagnosed any cancer type
You may not be if
Participants (patients) will be excluded if they:
* Are unable to give informed consent
* Are unable to speak English or Spanish
Clareo Health | Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials
